Delivery Order SPE2DR25D1205-SPE2DR26F0VW2
- Not listed
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $9,374.36 by the Defense Logistics Agency's Medical Supply Chain on July 23, 2025, for the supply of Tezspire 210 mg/1.91 ml pen injectors. This firm fixed-price, competitively awarded contract (without set-aside designation) is scheduled for completion by August 13, 2025, with performance at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $9,374.36 by the Defense Logistics Agency (DLA) on August 27, 2025, for the supply of Tezspire 210 mg/1.91 ml pen injectors. This is a firm fixed price, competitively awarded contract with no set-aside designation and a completion date of September 18, 2025. The award supports the company's role as a critical pharmaceutical distributor within the federal medical supply chain, with performance originating from the vendor's...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $9,374.36 by the Defense Logistics Agency (DLA) on April 24, 2025, for the supply of Tezspire 210 mg/1.91 mL pen injectors. This firm fixed-price delivery order, which carries an ultimate completion date of May 15, 2025, represents a competitive award with no set-aside designation. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen's corporate office is headquartered. This award is a child...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $9,374.36 by the Defense Logistics Agency's Medical Supply Chain on September 29, 2025, for the supply of Tezspire 210 mg/1.91 mL pen injectors. This non-set-aside, firm fixed-price contract is classified as a delivery order with an ultimate completion date of October 21, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a competitive delivery order valued at $46,871.80 by the Defense Logistics Agency on September 19, 2025. The contract calls for the supply of Tezspire 210 mg/1.91 mL pen injectors and is expected to be completed by October 10, 2025. This is a firm fixed-price delivery order with no set-aside designation, reflecting AmerisourceBergen's capability to compete successfully in open...
- The Defense Logistics Agency has awarded a delivery order valued at $4,939.58 to AmerisourceBergen Drug Corp for the supply of Tezspire 210 mg/1.91 mL pen injectors. This is a firm fixed price, competitively awarded contract with an ultimate completion date of November 28, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child delivery order under a larger contract vehicle, this award leverages AmerisourceBergen's...
- The Defense Logistics Agency awarded a $35,153.85 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Tezspire 210 mg/1.91 ml pen injectors. The contract, which is non-set-aside and competitively awarded, carries an ultimate completion date of September 3, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $2,343.59 on August 18, 2025, for the supply of Tezspire 210 mg/1.91 ml pen injectors. This is a firm fixed price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of September 9, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $2,343.59 by the Defense Logistics Agency on August 22, 2025, for the supply of Tezspire 210 mg/1.91 ml pen injectors. This competitively awarded, firm fixed-price contract carries an ultimate completion date of September 15, 2025, with performance to be fulfilled at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award involves no set-aside designation, reflecting the company's competitive standing in federal...
- The Defense Logistics Agency awarded a delivery order valued at $4,939.58 to AmerisourceBergen Drug Corp on October 31, 2025, for the supply of Tezspire 210 mg/1.91 ml pen injectors, with an ultimate completion date of November 24, 2025. This firm fixed price, competitively awarded delivery order (with no set-aside designation) is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's...
- SPE2DR25D1205Indefinite Delivery Contract
- SPE2DR25D1205-SPE2DR26F0VW2Delivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $9,879.12 by the Defense Logistics Agency on October 28, 2025, for the supply of Tezspire 210 mg/1.91 mL pen injectors. The contract is a firm fixed price delivery order with an ultimate completion date of November 19, 2025, and was competitively awarded with no set-aside designation. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. Tezspire is a specialty biologic medication used in the treatment of severe asthma, reflecting the company's role in delivering specialized healthcare commodities across multiple therapeutic domains to the Defense Health Agency and other government healthcare systems. The delivery order award demonstrates AmerisourceBergen's continued capability to fulfill federal medical procurement requirements through competitive contracting processes while supporting critical military medical supply needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.9k | 10/28/25 |